Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Income

v2.4.0.8
Consolidated Condensed Statements of Income (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Sep. 27, 2014
Sep. 28, 2013
Net revenue $ 14,554 $ 13,483 $ 41,149 $ 38,874
Cost of sales 5,096 5,069 15,161 15,924
Gross margin 9,458 8,414 25,988 22,950
Research and development 2,842 2,742 8,547 7,785
Marketing, general and administrative 1,979 1,970 6,087 6,082
Restructuring and asset impairment charges 20 124 238 124
Operating expenses 4,918 4,910 15,094 14,208
Operating income 4,540 3,504 10,894 8,742
Gains (losses) on equity investments, net 35 452 178 437
Interest and other, net (25) (32) 70 (119)
Income before taxes 4,550 3,924 11,142 9,060
Provision for taxes 1,233 974 3,099 2,065
Net income 3,317 2,950 8,043 6,995
Basic earnings per common share (in dollars per share) $ 0.68 $ 0.59 $ 1.63 $ 1.41
Diluted earnings per common share (in dollars per share) $ 0.66 $ 0.58 $ 1.58 $ 1.37
Cash dividends declared per common share (in dollars per share) $ 0.45 $ 0.45 $ 0.9 $ 0.90
Weighted average common shares outstanding:        
Basic (shares) 4,880 4,981 4,945 4,969
Diluted (shares) 5,045 5,100 5,095 5,095
Operating Expense [Member]
       
Amortization of acquisition-related intangibles $ 77 $ 74 $ 222 $ 217